• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便微生物群移植——对人类健康的当前观点

Fecal microbiota transplantation-current perspective on human health.

作者信息

Cao Zixuan, Gao Tingting, Bajinka Ousman, Zhang Yali, Yuan Xingxing

机构信息

Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China.

Country School of Medicine and Allied Health Sciences, University of The Gambia, Banjul, Gambia.

出版信息

Front Med (Lausanne). 2025 Mar 14;12:1523870. doi: 10.3389/fmed.2025.1523870. eCollection 2025.

DOI:10.3389/fmed.2025.1523870
PMID:40160324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11949973/
Abstract

Recently, microbiome medicine has attracted the attention of researchers. While this rapidly growing medical approach for various diseases and disorders is changing the paradigm, it is imperative to weigh both its benefits and the associated risk factors. For instance, manipulation of the gut microbiota (GM) has positive effects on metabolic and neurodegenerative diseases. Notably, fecal microbiota transplantation (FMT), a complex method, has shown promise; however, many doubt its feasibility without adverse effects on human health. Given the number of human clinical trials investigating FMT for the treatment of various disorders, this review summarizes recent findings on its impact on human health. This review summarizes the metabolic responses associated with FMT and their reversal effects on gastrointestinal infections, behavioral changes, and immune responses. Additionally, this review discusses the role of FMT in antimicrobial resistance and its co-supplementation effects on human health, safety, potential risks, limitations, prospects, and recommendations. Although this review does not cover all the studies in the database, the searched terms for FMT and human health in clinical trials are sufficient to provide a summary of the current perspective.

摘要

最近,微生物组医学已引起研究人员的关注。虽然这种针对各种疾病和病症迅速发展的医学方法正在改变范式,但权衡其益处和相关风险因素势在必行。例如,肠道微生物群(GM)的调控对代谢性疾病和神经退行性疾病具有积极影响。值得注意的是,粪便微生物群移植(FMT)这种复杂方法已显示出前景;然而,许多人怀疑其在不对人类健康产生不利影响的情况下的可行性。鉴于有大量针对FMT治疗各种病症的人体临床试验,本综述总结了其对人类健康影响的最新研究结果。本综述总结了与FMT相关的代谢反应及其对胃肠道感染、行为变化和免疫反应的逆转作用。此外,本综述讨论了FMT在抗菌耐药性中的作用及其对人类健康、安全性、潜在风险、局限性、前景和建议的联合补充效应。虽然本综述未涵盖数据库中的所有研究,但在临床试验中搜索FMT和人类健康的术语足以提供当前观点的总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea4/11949973/6070c4b92dce/fmed-12-1523870-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea4/11949973/6070c4b92dce/fmed-12-1523870-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea4/11949973/6070c4b92dce/fmed-12-1523870-g001.jpg

相似文献

1
Fecal microbiota transplantation-current perspective on human health.粪便微生物群移植——对人类健康的当前观点
Front Med (Lausanne). 2025 Mar 14;12:1523870. doi: 10.3389/fmed.2025.1523870. eCollection 2025.
2
Fecal microbiota transplantation for the treatment of intestinal and extra-intestinal diseases: Mechanism basis, clinical application, and potential prospect.粪便微生物群移植治疗肠道和肠道外疾病:机制基础、临床应用及潜在前景。
Bioeng Transl Med. 2024 Nov 7;10(2):e10728. doi: 10.1002/btm2.10728. eCollection 2025 Mar.
3
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy.从混乱到有序:优化粪便微生物群移植以提高免疫检查点抑制剂疗效
Gut Microbes. 2025 Dec;17(1):2452277. doi: 10.1080/19490976.2025.2452277. Epub 2025 Jan 18.
4
The role of the gut microbiome in colonization resistance and recurrent infection.肠道微生物群在定植抗性和反复感染中的作用。
Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022.
5
Gut-Liver-Brain Axis and Alcohol Use Disorder: Treatment Potential of Fecal Microbiota Transplantation.肠-肝-脑轴与酒精使用障碍:粪便微生物群移植的治疗潜力。
Alcohol Res. 2024 Feb 1;44(1):01. doi: 10.35946/arcr.v44.1.01. eCollection 2024.
6
Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.粪便微生物群移植百科全书:治疗 85 种疾病的有效性综述。
Chin Med J (Engl). 2022 Aug 20;135(16):1927-1939. doi: 10.1097/CM9.0000000000002339.
7
Fecal Microbiota Transplantation in Neurological Disorders.粪便微生物移植在神经疾病中的应用。
Front Cell Infect Microbiol. 2020 Mar 24;10:98. doi: 10.3389/fcimb.2020.00098. eCollection 2020.
8
The Evolving Landscape of Fecal Microbial Transplantation.粪便微生物移植的演变格局。
Clin Rev Allergy Immunol. 2023 Oct;65(2):101-120. doi: 10.1007/s12016-023-08958-0. Epub 2023 Feb 9.
9
Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay.粪便微生物群移植:应用场景、疗效预测及影响供体-受体相互作用的因素
Front Microbiol. 2025 Mar 25;16:1556827. doi: 10.3389/fmicb.2025.1556827. eCollection 2025.
10
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.

本文引用的文献

1
Effects of fecal microbiota transplantation combined with selenium on intestinal microbiota in mice with colorectal cancer.粪便微生物群移植联合硒对结直肠癌小鼠肠道微生物群的影响。
Biochem Biophys Res Commun. 2024 Nov 12;733:150580. doi: 10.1016/j.bbrc.2024.150580. Epub 2024 Aug 22.
2
Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.一项粪便微生物群移植试验的多组学分析揭示了急性移植物抗宿主病发病机制的新方面。
Cancer Res Commun. 2024 Jun 10;4(6):1454-1466. doi: 10.1158/2767-9764.CRC-24-0138.
3
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
接受者微生物组相关特征预测肥胖合并代谢综合征成人接受粪便微生物群移植后代谢改善:一项 2 期临床试验的二次分析。
Gut Microbes. 2024 Jan-Dec;16(1):2345134. doi: 10.1080/19490976.2024.2345134. Epub 2024 Apr 29.
4
Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation.接受粪便微生物群移植的慢性肾脏病患者疾病进展的变化
Nutrients. 2024 Apr 10;16(8):1109. doi: 10.3390/nu16081109.
5
Immunoregulatory role of the gut microbiota in inflammatory depression.肠道微生物群在炎症性抑郁症中的免疫调节作用。
Nat Commun. 2024 Apr 8;15(1):3003. doi: 10.1038/s41467-024-47273-w.
6
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial.粪便微生物群移植对抗生素耐药基因的长期和短期影响:一项随机安慰剂对照试验的结果。
Gut Microbes. 2024 Jan-Dec;16(1):2327442. doi: 10.1080/19490976.2024.2327442. Epub 2024 Mar 13.
7
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.第三方粪便微生物群移植治疗高危初治急性下胃肠道移植物抗宿主病。
Blood Adv. 2024 May 14;8(9):2074-2084. doi: 10.1182/bloodadvances.2024012556.
8
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms.影响严重和中度肠易激综合征患者粪便微生物移植疗效差异的因素。
Dig Dis Sci. 2024 Apr;69(4):1336-1344. doi: 10.1007/s10620-024-08369-x. Epub 2024 Mar 6.
9
The connection between epigenetics and gut microbiota-current perspective.表观遗传学与肠道微生物组的关联:当前的观点。
Cell Biochem Funct. 2024 Mar;42(2):e3941. doi: 10.1002/cbf.3941.
10
Donor-recipient intermicrobial interactions impact transfer of subspecies and fecal microbiota transplantation outcome.供体-受体间微生物相互作用影响亚种转移和粪便微生物群移植的结果。
Cell Host Microbe. 2024 Mar 13;32(3):349-365.e4. doi: 10.1016/j.chom.2024.01.013. Epub 2024 Feb 16.